Executive Director, Haematology/Oncology Business Unit Lead, UK & Ireland

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us . Executive Director, Haematology/Oncology Business Unit Lead, UK & Ireland Band EG-170 Division Commercialization Location UK (Uxbridge) Reports To General Manager UK & Ireland At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology, and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference. Purpose ·     Under the direction of the General Manager, this individual will be responsible for the leadership and commercial success of the Haematology/Oncology business unit. ·     The individual will oversee and lead the development and execution of the Innovative Medicines strategic business plan including the integrated functions ·     As a member of the UKI leadership team, the individual is expected to operate in close coordination and collaboration with her/his peers at the local level as well as with partners in the WW organisation and across Major Markets ·     Whilst the primary focus will be on the execution of the current portfolio strategy, the individual will also be responsible for steering the follow-on Innovative Medicines pipeline. The role is a key leadership role in the further transformation of the UK/Ireland Innovative Medicines business by managing a broad highly innovative product portfolio For BMS Internal Use Only Role and Responsibilities: ·     Successfully implement the New Commercialization Model for the BU in alignment with the country PMO ·     Develop, implement and maintain marketing, sales and access strategies and tactics for Innovative Medicines portfolio (including new indications) to meet the organisational objectives. ·     Collaborate closely with Medical Affairs, Market Access, Corporate Affairs, Regulatory, BIA and other functions for the overall brand strategies and tactics for Innovative Medicines portfolio. ·     Lead cross-functional team to drive execution of the complex multi-product and indication portfolio strategy, for in-line and future launch indications across the Innovative Medicines pipeline ·     Develop and deliver national patient and sales forecast/budget targets of Innovative Medicines product portfolio; monitor and report deviations and implement corrective and actions if appropriate. ·     Manage the Innovative Medicines Business Unit Sales & Expense Budget and overall P&L. Deliver all marketing and sales activities within the agreed budget. ·     Lead collaborative efforts with the international/global teams to develop & execute the overall brand strategies and operating plans – including Omnichannel - for Innovative Medicines portfolio ·     Manage the critical linkage between late-stage development, commercial planning, launch management, on-going sales support and marketing. Utilize effective life cycle